Weight Stigma in Women Who Are Obese: Assessing How an Acute Exposure to Stigma Negatively Impacts Cardiovascular Health
NCT ID: NCT04161638
Last Updated: 2022-05-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
49 participants
INTERVENTIONAL
2016-11-22
2019-01-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Weight Discrimination and Poor Cardiovascular Health
NCT05714696
Psychobiological Processes in Social Evaluation
NCT05107609
Evaluation of a Health at Every Size vs a Behavioral Weight Loss Approach for Obese Women
NCT00769717
Cardiovascular Health in Postpartum Women Diagnosed With Excessive Gestational Weight Gain
NCT02142452
Targeting Body Image Among Women of Higher Body Weight
NCT04810247
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
High Blood Pressure
Ambulatory BP measurement was used to confirm the laboratory BP group classification according to the European Society of Hypertension. Participants were placed in the high blood pressure (HBP) group if they met any of the following criteria: 1) 19-hour average systolic BP/diastolic BP (SBP/DBP) \> 130/80 mmHg, 2) daytime (awake) average SBP/DBP \> 135/85 mmHg, or 3) nighttime (sleep) average SBP/DBP \> 120/70 mmHg.
Stigma Video Exposure
The participants watched a 10 minute video on a computer screen that consisted of brief clips from popular television shows that depicted women with overweight and obesity and evoked negative weight-based stereotypes (e.g., clumsy, loud, and lazy). Both the high blood pressure and normal blood pressure arms participated in this intervention.
Neutral video exposure
The participants watched a 10 minute video on a computer screen that consisted of a series of clips depicting neutral scenes (e.g., insurance commercials). Both the high blood pressure and normal blood pressure arms participated in this intervention.
Normal Blood Pressure
Participants were placed in the normal BP (NBP) group if they met all of the following criteria: 1) 19-hour average SBP/DBP \< 130/80 mmHg, 2) daytime (awake) average SBP/DBP \< 135/85 mmHg, and 3) night-time (asleep) average SBP/DBP \<120/70 mmHg.
Stigma Video Exposure
The participants watched a 10 minute video on a computer screen that consisted of brief clips from popular television shows that depicted women with overweight and obesity and evoked negative weight-based stereotypes (e.g., clumsy, loud, and lazy). Both the high blood pressure and normal blood pressure arms participated in this intervention.
Neutral video exposure
The participants watched a 10 minute video on a computer screen that consisted of a series of clips depicting neutral scenes (e.g., insurance commercials). Both the high blood pressure and normal blood pressure arms participated in this intervention.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Stigma Video Exposure
The participants watched a 10 minute video on a computer screen that consisted of brief clips from popular television shows that depicted women with overweight and obesity and evoked negative weight-based stereotypes (e.g., clumsy, loud, and lazy). Both the high blood pressure and normal blood pressure arms participated in this intervention.
Neutral video exposure
The participants watched a 10 minute video on a computer screen that consisted of a series of clips depicting neutral scenes (e.g., insurance commercials). Both the high blood pressure and normal blood pressure arms participated in this intervention.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI \> 30 kg/m2
* No other known chronic cardiovascular or metabolic diseases besides hypertension
Exclusion Criteria
* Took medications that may have affected the primary outcome of BP (e.g., stimulants for attention deficit hyperactivity disorder or steroids for asthma)
* Currently using tobacco products
* Diagnosed with an eating disorder
20 Years
50 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hartford Hospital
OTHER
University of Connecticut
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Linda Pescatello
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Beth A Taylor, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Connecticut
Linda S Pescatello, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Connecticut
Rebecca Puhl, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Connecticut
References
Explore related publications, articles, or registry entries linked to this study.
Panza GA, Puhl RM, Taylor BA, Cilhoroz B, Himmelstein MS, Fernandez AB, Pescatello LS. The effects of an acute weight stigma exposure on cardiovascular reactivity among women with obesity and hypertension: A randomized trial. J Psychosom Res. 2023 Feb;165:111124. doi: 10.1016/j.jpsychores.2022.111124. Epub 2022 Dec 21.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H16-292HHC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.